筋肉内注射用懸濁液のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Intramuscular Injectable Suspensions Market Insights, Forecast to 2028

• レポートコード：QY2203B08523
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の筋肉内注射用懸濁液の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に筋肉内注射用懸濁液の世界市場のxxx％を占める「一回分」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の筋肉内注射用懸濁液の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの筋肉内注射用懸濁液市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの筋肉内注射用懸濁液市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

筋肉内注射用懸濁液のグローバル主要メーカーには、Merck Sharp & Dohme、Novo Nordisk、Lilly、Biocon Limited、Pfizer、BeiGene、EnteraBio、AbbVie、Pfizer Limited、Teva Pharmaceuticals USA、Bristol-Myers Squibb、Cipla、Baxter International、AstraZenecaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

筋肉内注射用懸濁液市場は、種類と用途によって区分されます。世界の筋肉内注射用懸濁液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
一回分、複数回分

【用途別セグメント】
病院薬局、小売薬局、オンライン薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 筋肉内注射用懸濁液製品概要
- 種類別市場（一回分、複数回分）
- 用途別市場（病院薬局、小売薬局、オンライン薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の筋肉内注射用懸濁液販売量予測2017-2028
- 世界の筋肉内注射用懸濁液売上予測2017-2028
- 筋肉内注射用懸濁液の地域別販売量
- 筋肉内注射用懸濁液の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別筋肉内注射用懸濁液販売量
- 主要メーカー別筋肉内注射用懸濁液売上
- 主要メーカー別筋肉内注射用懸濁液価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（一回分、複数回分）
- 筋肉内注射用懸濁液の種類別販売量
- 筋肉内注射用懸濁液の種類別売上
- 筋肉内注射用懸濁液の種類別価格
・用途別市場規模（病院薬局、小売薬局、オンライン薬局）
- 筋肉内注射用懸濁液の用途別販売量
- 筋肉内注射用懸濁液の用途別売上
- 筋肉内注射用懸濁液の用途別価格
・北米市場
- 北米の筋肉内注射用懸濁液市場規模（種類別、用途別）
- 主要国別の筋肉内注射用懸濁液市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの筋肉内注射用懸濁液市場規模（種類別、用途別）
- 主要国別の筋肉内注射用懸濁液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の筋肉内注射用懸濁液市場規模（種類別、用途別）
- 主要国別の筋肉内注射用懸濁液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の筋肉内注射用懸濁液市場規模（種類別、用途別）
- 主要国別の筋肉内注射用懸濁液市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの筋肉内注射用懸濁液市場規模（種類別、用途別）
- 主要国別の筋肉内注射用懸濁液市場規模（トルコ、サウジアラビア）
・企業情報
Merck Sharp & Dohme、Novo Nordisk、Lilly、Biocon Limited、Pfizer、BeiGene、EnteraBio、AbbVie、Pfizer Limited、Teva Pharmaceuticals USA、Bristol-Myers Squibb、Cipla、Baxter International、AstraZeneca
・産業チェーン及び販売チャネル分析
- 筋肉内注射用懸濁液の産業チェーン分析
- 筋肉内注射用懸濁液の原材料
- 筋肉内注射用懸濁液の生産プロセス
- 筋肉内注射用懸濁液の販売及びマーケティング
- 筋肉内注射用懸濁液の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 筋肉内注射用懸濁液の産業動向
- 筋肉内注射用懸濁液のマーケットドライバー
- 筋肉内注射用懸濁液の課題
- 筋肉内注射用懸濁液の阻害要因
・主な調査結果

Market Analysis and Insights: Global Intramuscular Injectable Suspensions Market
Due to the COVID-19 pandemic, the global Intramuscular Injectable Suspensions market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Single-Dose Injections accounting for % of the Intramuscular Injectable Suspensions global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Intramuscular Injectable Suspensions market size is valued at US$ million in 2021, while the US and Europe Intramuscular Injectable Suspensions are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Intramuscular Injectable Suspensions landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Intramuscular Injectable Suspensions include Merck Sharp & Dohme, Novo Nordisk, Lilly, Biocon Limited, Pfizer, BeiGene, EnteraBio, AbbVie and Pfizer Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Intramuscular Injectable Suspensions Scope and Segment
Intramuscular Injectable Suspensions market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intramuscular Injectable Suspensions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Single-Dose Injections
Multiple-Dose Injections
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Company
Merck Sharp & Dohme
Novo Nordisk
Lilly
Biocon Limited
Pfizer
BeiGene
EnteraBio
AbbVie
Pfizer Limited
Teva Pharmaceuticals USA
Bristol-Myers Squibb
Cipla
Baxter International
AstraZeneca
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Intramuscular Injectable Suspensions Product Introduction
1.2 Market by Type
1.2.1 Global Intramuscular Injectable Suspensions Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single-Dose Injections
1.2.3 Multiple-Dose Injections
1.3 Market by Application
1.3.1 Global Intramuscular Injectable Suspensions Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intramuscular Injectable Suspensions Sales Estimates and Forecasts 2017-2028
2.2 Global Intramuscular Injectable Suspensions Revenue Estimates and Forecasts 2017-2028
2.3 Global Intramuscular Injectable Suspensions Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intramuscular Injectable Suspensions Sales by Region
2.4.1 Global Intramuscular Injectable Suspensions Sales by Region (2017-2022)
2.4.2 Global Sales Intramuscular Injectable Suspensions by Region (2023-2028)
2.5 Global Intramuscular Injectable Suspensions Revenue by Region
2.5.1 Global Intramuscular Injectable Suspensions Revenue by Region (2017-2022)
2.5.2 Global Intramuscular Injectable Suspensions Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intramuscular Injectable Suspensions Sales by Manufacturers
3.1.1 Global Top Intramuscular Injectable Suspensions Manufacturers by Sales (2017-2022)
3.1.2 Global Intramuscular Injectable Suspensions Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intramuscular Injectable Suspensions in 2021
3.2 Global Intramuscular Injectable Suspensions Revenue by Manufacturers
3.2.1 Global Intramuscular Injectable Suspensions Revenue by Manufacturers (2017-2022)
3.2.2 Global Intramuscular Injectable Suspensions Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intramuscular Injectable Suspensions Revenue in 2021
3.3 Global Intramuscular Injectable Suspensions Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intramuscular Injectable Suspensions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intramuscular Injectable Suspensions Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intramuscular Injectable Suspensions Sales by Type
4.1.1 Global Intramuscular Injectable Suspensions Historical Sales by Type (2017-2022)
4.1.2 Global Intramuscular Injectable Suspensions Forecasted Sales by Type (2023-2028)
4.1.3 Global Intramuscular Injectable Suspensions Sales Market Share by Type (2017-2028)
4.2 Global Intramuscular Injectable Suspensions Revenue by Type
4.2.1 Global Intramuscular Injectable Suspensions Historical Revenue by Type (2017-2022)
4.2.2 Global Intramuscular Injectable Suspensions Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intramuscular Injectable Suspensions Revenue Market Share by Type (2017-2028)
4.3 Global Intramuscular Injectable Suspensions Price by Type
4.3.1 Global Intramuscular Injectable Suspensions Price by Type (2017-2022)
4.3.2 Global Intramuscular Injectable Suspensions Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intramuscular Injectable Suspensions Sales by Application
5.1.1 Global Intramuscular Injectable Suspensions Historical Sales by Application (2017-2022)
5.1.2 Global Intramuscular Injectable Suspensions Forecasted Sales by Application (2023-2028)
5.1.3 Global Intramuscular Injectable Suspensions Sales Market Share by Application (2017-2028)
5.2 Global Intramuscular Injectable Suspensions Revenue by Application
5.2.1 Global Intramuscular Injectable Suspensions Historical Revenue by Application (2017-2022)
5.2.2 Global Intramuscular Injectable Suspensions Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intramuscular Injectable Suspensions Revenue Market Share by Application (2017-2028)
5.3 Global Intramuscular Injectable Suspensions Price by Application
5.3.1 Global Intramuscular Injectable Suspensions Price by Application (2017-2022)
5.3.2 Global Intramuscular Injectable Suspensions Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intramuscular Injectable Suspensions Market Size by Type
6.1.1 North America Intramuscular Injectable Suspensions Sales by Type (2017-2028)
6.1.2 North America Intramuscular Injectable Suspensions Revenue by Type (2017-2028)
6.2 North America Intramuscular Injectable Suspensions Market Size by Application
6.2.1 North America Intramuscular Injectable Suspensions Sales by Application (2017-2028)
6.2.2 North America Intramuscular Injectable Suspensions Revenue by Application (2017-2028)
6.3 North America Intramuscular Injectable Suspensions Market Size by Country
6.3.1 North America Intramuscular Injectable Suspensions Sales by Country (2017-2028)
6.3.2 North America Intramuscular Injectable Suspensions Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intramuscular Injectable Suspensions Market Size by Type
7.1.1 Europe Intramuscular Injectable Suspensions Sales by Type (2017-2028)
7.1.2 Europe Intramuscular Injectable Suspensions Revenue by Type (2017-2028)
7.2 Europe Intramuscular Injectable Suspensions Market Size by Application
7.2.1 Europe Intramuscular Injectable Suspensions Sales by Application (2017-2028)
7.2.2 Europe Intramuscular Injectable Suspensions Revenue by Application (2017-2028)
7.3 Europe Intramuscular Injectable Suspensions Market Size by Country
7.3.1 Europe Intramuscular Injectable Suspensions Sales by Country (2017-2028)
7.3.2 Europe Intramuscular Injectable Suspensions Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intramuscular Injectable Suspensions Market Size by Type
8.1.1 Asia Pacific Intramuscular Injectable Suspensions Sales by Type (2017-2028)
8.1.2 Asia Pacific Intramuscular Injectable Suspensions Revenue by Type (2017-2028)
8.2 Asia Pacific Intramuscular Injectable Suspensions Market Size by Application
8.2.1 Asia Pacific Intramuscular Injectable Suspensions Sales by Application (2017-2028)
8.2.2 Asia Pacific Intramuscular Injectable Suspensions Revenue by Application (2017-2028)
8.3 Asia Pacific Intramuscular Injectable Suspensions Market Size by Region
8.3.1 Asia Pacific Intramuscular Injectable Suspensions Sales by Region (2017-2028)
8.3.2 Asia Pacific Intramuscular Injectable Suspensions Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intramuscular Injectable Suspensions Market Size by Type
9.1.1 Latin America Intramuscular Injectable Suspensions Sales by Type (2017-2028)
9.1.2 Latin America Intramuscular Injectable Suspensions Revenue by Type (2017-2028)
9.2 Latin America Intramuscular Injectable Suspensions Market Size by Application
9.2.1 Latin America Intramuscular Injectable Suspensions Sales by Application (2017-2028)
9.2.2 Latin America Intramuscular Injectable Suspensions Revenue by Application (2017-2028)
9.3 Latin America Intramuscular Injectable Suspensions Market Size by Country
9.3.1 Latin America Intramuscular Injectable Suspensions Sales by Country (2017-2028)
9.3.2 Latin America Intramuscular Injectable Suspensions Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intramuscular Injectable Suspensions Market Size by Type
10.1.1 Middle East and Africa Intramuscular Injectable Suspensions Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intramuscular Injectable Suspensions Revenue by Type (2017-2028)
10.2 Middle East and Africa Intramuscular Injectable Suspensions Market Size by Application
10.2.1 Middle East and Africa Intramuscular Injectable Suspensions Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intramuscular Injectable Suspensions Revenue by Application (2017-2028)
10.3 Middle East and Africa Intramuscular Injectable Suspensions Market Size by Country
10.3.1 Middle East and Africa Intramuscular Injectable Suspensions Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intramuscular Injectable Suspensions Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck Sharp & Dohme
11.1.1 Merck Sharp & Dohme Corporation Information
11.1.2 Merck Sharp & Dohme Overview
11.1.3 Merck Sharp & Dohme Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Sharp & Dohme Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Sharp & Dohme Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Overview
11.2.3 Novo Nordisk Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novo Nordisk Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novo Nordisk Recent Developments
11.3 Lilly
11.3.1 Lilly Corporation Information
11.3.2 Lilly Overview
11.3.3 Lilly Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Lilly Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lilly Recent Developments
11.4 Biocon Limited
11.4.1 Biocon Limited Corporation Information
11.4.2 Biocon Limited Overview
11.4.3 Biocon Limited Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biocon Limited Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biocon Limited Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 BeiGene
11.6.1 BeiGene Corporation Information
11.6.2 BeiGene Overview
11.6.3 BeiGene Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BeiGene Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BeiGene Recent Developments
11.7 EnteraBio
11.7.1 EnteraBio Corporation Information
11.7.2 EnteraBio Overview
11.7.3 EnteraBio Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 EnteraBio Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 EnteraBio Recent Developments
11.8 AbbVie
11.8.1 AbbVie Corporation Information
11.8.2 AbbVie Overview
11.8.3 AbbVie Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AbbVie Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AbbVie Recent Developments
11.9 Pfizer Limited
11.9.1 Pfizer Limited Corporation Information
11.9.2 Pfizer Limited Overview
11.9.3 Pfizer Limited Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pfizer Limited Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pfizer Limited Recent Developments
11.10 Teva Pharmaceuticals USA
11.10.1 Teva Pharmaceuticals USA Corporation Information
11.10.2 Teva Pharmaceuticals USA Overview
11.10.3 Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceuticals USA Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Corporation Information
11.11.2 Bristol-Myers Squibb Overview
11.11.3 Bristol-Myers Squibb Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bristol-Myers Squibb Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 Cipla
11.12.1 Cipla Corporation Information
11.12.2 Cipla Overview
11.12.3 Cipla Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Cipla Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Cipla Recent Developments
11.13 Baxter International
11.13.1 Baxter International Corporation Information
11.13.2 Baxter International Overview
11.13.3 Baxter International Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Baxter International Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Baxter International Recent Developments
11.14 AstraZeneca
11.14.1 AstraZeneca Corporation Information
11.14.2 AstraZeneca Overview
11.14.3 AstraZeneca Intramuscular Injectable Suspensions Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 AstraZeneca Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 AstraZeneca Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intramuscular Injectable Suspensions Industry Chain Analysis
12.2 Intramuscular Injectable Suspensions Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intramuscular Injectable Suspensions Production Mode & Process
12.4 Intramuscular Injectable Suspensions Sales and Marketing
12.4.1 Intramuscular Injectable Suspensions Sales Channels
12.4.2 Intramuscular Injectable Suspensions Distributors
12.5 Intramuscular Injectable Suspensions Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intramuscular Injectable Suspensions Industry Trends
13.2 Intramuscular Injectable Suspensions Market Drivers
13.3 Intramuscular Injectable Suspensions Market Challenges
13.4 Intramuscular Injectable Suspensions Market Restraints
14 Key Findings in The Global Intramuscular Injectable Suspensions Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Intramuscular Injectable Suspensions Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Single-Dose Injections
Table 3. Major Manufacturers of Multiple-Dose Injections
Table 4. Global Intramuscular Injectable Suspensions Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Intramuscular Injectable Suspensions Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Intramuscular Injectable Suspensions Sales by Region (2017-2022) & (K Units)
Table 7. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2017-2022)
Table 8. Global Intramuscular Injectable Suspensions Sales by Region (2023-2028) & (K Units)
Table 9. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2023-2028)
Table 10. Global Intramuscular Injectable Suspensions Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Intramuscular Injectable Suspensions Revenue Market Share by Region (2017-2022)
Table 12. Global Intramuscular Injectable Suspensions Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Intramuscular Injectable Suspensions Revenue Market Share by Region (2023-2028)
Table 14. Global Intramuscular Injectable Suspensions Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Intramuscular Injectable Suspensions Sales Share by Manufacturers (2017-2022)
Table 16. Global Intramuscular Injectable Suspensions Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Intramuscular Injectable Suspensions Revenue Share by Manufacturers (2017-2022)
Table 18. Intramuscular Injectable Suspensions Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Intramuscular Injectable Suspensions Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Intramuscular Injectable Suspensions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Injectable Suspensions as of 2021)
Table 21. Intramuscular Injectable Suspensions Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Intramuscular Injectable Suspensions Product Offered
Table 23. Date of Manufacturers Enter into Intramuscular Injectable Suspensions Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intramuscular Injectable Suspensions Sales by Type (2017-2022) & (K Units)
Table 26. Global Intramuscular Injectable Suspensions Sales by Type (2023-2028) & (K Units)
Table 27. Global Intramuscular Injectable Suspensions Sales Share by Type (2017-2022)
Table 28. Global Intramuscular Injectable Suspensions Sales Share by Type (2023-2028)
Table 29. Global Intramuscular Injectable Suspensions Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Intramuscular Injectable Suspensions Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Intramuscular Injectable Suspensions Revenue Share by Type (2017-2022)
Table 32. Global Intramuscular Injectable Suspensions Revenue Share by Type (2023-2028)
Table 33. Intramuscular Injectable Suspensions Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Intramuscular Injectable Suspensions Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Intramuscular Injectable Suspensions Sales by Application (2017-2022) & (K Units)
Table 36. Global Intramuscular Injectable Suspensions Sales by Application (2023-2028) & (K Units)
Table 37. Global Intramuscular Injectable Suspensions Sales Share by Application (2017-2022)
Table 38. Global Intramuscular Injectable Suspensions Sales Share by Application (2023-2028)
Table 39. Global Intramuscular Injectable Suspensions Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Intramuscular Injectable Suspensions Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Intramuscular Injectable Suspensions Revenue Share by Application (2017-2022)
Table 42. Global Intramuscular Injectable Suspensions Revenue Share by Application (2023-2028)
Table 43. Intramuscular Injectable Suspensions Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Intramuscular Injectable Suspensions Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Intramuscular Injectable Suspensions Sales by Type (2017-2022) & (K Units)
Table 46. North America Intramuscular Injectable Suspensions Sales by Type (2023-2028) & (K Units)
Table 47. North America Intramuscular Injectable Suspensions Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Intramuscular Injectable Suspensions Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Intramuscular Injectable Suspensions Sales by Application (2017-2022) & (K Units)
Table 50. North America Intramuscular Injectable Suspensions Sales by Application (2023-2028) & (K Units)
Table 51. North America Intramuscular Injectable Suspensions Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Intramuscular Injectable Suspensions Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Intramuscular Injectable Suspensions Sales by Country (2017-2022) & (K Units)
Table 54. North America Intramuscular Injectable Suspensions Sales by Country (2023-2028) & (K Units)
Table 55. North America Intramuscular Injectable Suspensions Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Intramuscular Injectable Suspensions Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Intramuscular Injectable Suspensions Sales by Type (2017-2022) & (K Units)
Table 58. Europe Intramuscular Injectable Suspensions Sales by Type (2023-2028) & (K Units)
Table 59. Europe Intramuscular Injectable Suspensions Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Intramuscular Injectable Suspensions Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Intramuscular Injectable Suspensions Sales by Application (2017-2022) & (K Units)
Table 62. Europe Intramuscular Injectable Suspensions Sales by Application (2023-2028) & (K Units)
Table 63. Europe Intramuscular Injectable Suspensions Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Intramuscular Injectable Suspensions Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Intramuscular Injectable Suspensions Sales by Country (2017-2022) & (K Units)
Table 66. Europe Intramuscular Injectable Suspensions Sales by Country (2023-2028) & (K Units)
Table 67. Europe Intramuscular Injectable Suspensions Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Intramuscular Injectable Suspensions Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Intramuscular Injectable Suspensions Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Intramuscular Injectable Suspensions Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Intramuscular Injectable Suspensions Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Intramuscular Injectable Suspensions Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Intramuscular Injectable Suspensions Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Intramuscular Injectable Suspensions Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Intramuscular Injectable Suspensions Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Intramuscular Injectable Suspensions Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Intramuscular Injectable Suspensions Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Intramuscular Injectable Suspensions Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Intramuscular Injectable Suspensions Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Intramuscular Injectable Suspensions Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Intramuscular Injectable Suspensions Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Intramuscular Injectable Suspensions Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Intramuscular Injectable Suspensions Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Intramuscular Injectable Suspensions Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Intramuscular Injectable Suspensions Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Intramuscular Injectable Suspensions Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Intramuscular Injectable Suspensions Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Intramuscular Injectable Suspensions Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Intramuscular Injectable Suspensions Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Intramuscular Injectable Suspensions Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Intramuscular Injectable Suspensions Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Intramuscular Injectable Suspensions Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Intramuscular Injectable Suspensions Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Intramuscular Injectable Suspensions Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Intramuscular Injectable Suspensions Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Intramuscular Injectable Suspensions Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Intramuscular Injectable Suspensions Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Intramuscular Injectable Suspensions Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Intramuscular Injectable Suspensions Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Intramuscular Injectable Suspensions Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Intramuscular Injectable Suspensions Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Intramuscular Injectable Suspensions Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Sharp & Dohme Corporation Information
Table 106. Merck Sharp & Dohme Description and Major Businesses
Table 107. Merck Sharp & Dohme Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Merck Sharp & Dohme Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Sharp & Dohme Recent Developments
Table 110. Novo Nordisk Corporation Information
Table 111. Novo Nordisk Description and Major Businesses
Table 112. Novo Nordisk Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Novo Nordisk Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novo Nordisk Recent Developments
Table 115. Lilly Corporation Information
Table 116. Lilly Description and Major Businesses
Table 117. Lilly Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Lilly Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Lilly Recent Developments
Table 120. Biocon Limited Corporation Information
Table 121. Biocon Limited Description and Major Businesses
Table 122. Biocon Limited Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Biocon Limited Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Biocon Limited Recent Developments
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Major Businesses
Table 127. Pfizer Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Pfizer Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Recent Developments
Table 130. BeiGene Corporation Information
Table 131. BeiGene Description and Major Businesses
Table 132. BeiGene Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. BeiGene Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. BeiGene Recent Developments
Table 135. EnteraBio Corporation Information
Table 136. EnteraBio Description and Major Businesses
Table 137. EnteraBio Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. EnteraBio Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. EnteraBio Recent Developments
Table 140. AbbVie Corporation Information
Table 141. AbbVie Description and Major Businesses
Table 142. AbbVie Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. AbbVie Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AbbVie Recent Developments
Table 145. Pfizer Limited Corporation Information
Table 146. Pfizer Limited Description and Major Businesses
Table 147. Pfizer Limited Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Pfizer Limited Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Pfizer Limited Recent Developments
Table 150. Teva Pharmaceuticals USA Corporation Information
Table 151. Teva Pharmaceuticals USA Description and Major Businesses
Table 152. Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Teva Pharmaceuticals USA Recent Developments
Table 155. Bristol-Myers Squibb Corporation Information
Table 156. Bristol-Myers Squibb Description and Major Businesses
Table 157. Bristol-Myers Squibb Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Bristol-Myers Squibb Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Bristol-Myers Squibb Recent Developments
Table 160. Cipla Corporation Information
Table 161. Cipla Description and Major Businesses
Table 162. Cipla Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Cipla Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Cipla Recent Developments
Table 165. Baxter International Corporation Information
Table 166. Baxter International Description and Major Businesses
Table 167. Baxter International Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Baxter International Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Baxter International Recent Developments
Table 170. AstraZeneca Corporation Information
Table 171. AstraZeneca Description and Major Businesses
Table 172. AstraZeneca Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. AstraZeneca Intramuscular Injectable Suspensions Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. AstraZeneca Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Intramuscular Injectable Suspensions Distributors List
Table 178. Intramuscular Injectable Suspensions Customers List
Table 179. Intramuscular Injectable Suspensions Market Trends
Table 180. Intramuscular Injectable Suspensions Market Drivers
Table 181. Intramuscular Injectable Suspensions Market Challenges
Table 182. Intramuscular Injectable Suspensions Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Intramuscular Injectable Suspensions Product Picture
Figure 3. Global Intramuscular Injectable Suspensions Market Share by Type in 2021 & 2028
Figure 3. Single-Dose Injections Product Picture
Figure 4. Multiple-Dose Injections Product Picture
Figure 5. Global Intramuscular Injectable Suspensions Market Share by Application in 2021 & 2028
Figure 6. Hospitals Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Intramuscular Injectable Suspensions Report Years Considered
Figure 10. Global Intramuscular Injectable Suspensions Sales 2017-2028 (K Units)
Figure 11. Global Intramuscular Injectable Suspensions Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Intramuscular Injectable Suspensions Revenue 2017-2028 (US$ Million)
Figure 13. Global Intramuscular Injectable Suspensions Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2017-2022)
Figure 15. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2023-2028)
Figure 16. North America Intramuscular Injectable Suspensions Sales YoY (2017-2028) & (K Units)
Figure 17. North America Intramuscular Injectable Suspensions Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Intramuscular Injectable Suspensions Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Intramuscular Injectable Suspensions Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Intramuscular Injectable Suspensions Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Intramuscular Injectable Suspensions Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Intramuscular Injectable Suspensions Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Intramuscular Injectable Suspensions Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Intramuscular Injectable Suspensions Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Intramuscular Injectable Suspensions Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Intramuscular Injectable Suspensions Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Intramuscular Injectable Suspensions in the World: Market Share by Intramuscular Injectable Suspensions Revenue in 2021
Figure 28. Global Intramuscular Injectable Suspensions Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Intramuscular Injectable Suspensions Sales Market Share by Type (2017-2028)
Figure 30. Global Intramuscular Injectable Suspensions Revenue Market Share by Type (2017-2028)
Figure 31. Global Intramuscular Injectable Suspensions Sales Market Share by Application (2017-2028)
Figure 32. Global Intramuscular Injectable Suspensions Revenue Market Share by Application (2017-2028)
Figure 33. North America Intramuscular Injectable Suspensions Sales Market Share by Type (2017-2028)
Figure 34. North America Intramuscular Injectable Suspensions Revenue Market Share by Type (2017-2028)
Figure 35. North America Intramuscular Injectable Suspensions Sales Market Share by Application (2017-2028)
Figure 36. North America Intramuscular Injectable Suspensions Revenue Market Share by Application (2017-2028)
Figure 37. North America Intramuscular Injectable Suspensions Sales Share by Country (2017-2028)
Figure 38. North America Intramuscular Injectable Suspensions Revenue Share by Country (2017-2028)
Figure 39. United States Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Intramuscular Injectable Suspensions Sales Market Share by Type (2017-2028)
Figure 42. Europe Intramuscular Injectable Suspensions Revenue Market Share by Type (2017-2028)
Figure 43. Europe Intramuscular Injectable Suspensions Sales Market Share by Application (2017-2028)
Figure 44. Europe Intramuscular Injectable Suspensions Revenue Market Share by Application (2017-2028)
Figure 45. Europe Intramuscular Injectable Suspensions Sales Share by Country (2017-2028)
Figure 46. Europe Intramuscular Injectable Suspensions Revenue Share by Country (2017-2028)
Figure 47. Germany Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 48. France Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Intramuscular Injectable Suspensions Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Intramuscular Injectable Suspensions Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Intramuscular Injectable Suspensions Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Intramuscular Injectable Suspensions Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Intramuscular Injectable Suspensions Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Intramuscular Injectable Suspensions Revenue Share by Region (2017-2028)
Figure 58. China Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 61. India Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Intramuscular Injectable Suspensions Sales Market Share by Type (2017-2028)
Figure 68. Latin America Intramuscular Injectable Suspensions Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Intramuscular Injectable Suspensions Sales Market Share by Application (2017-2028)
Figure 70. Latin America Intramuscular Injectable Suspensions Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Intramuscular Injectable Suspensions Sales Share by Country (2017-2028)
Figure 72. Latin America Intramuscular Injectable Suspensions Revenue Share by Country (2017-2028)
Figure 73. Mexico Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Intramuscular Injectable Suspensions Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Intramuscular Injectable Suspensions Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Intramuscular Injectable Suspensions Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Intramuscular Injectable Suspensions Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Intramuscular Injectable Suspensions Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Intramuscular Injectable Suspensions Revenue Share by Country (2017-2028)
Figure 82. Turkey Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Intramuscular Injectable Suspensions Revenue (2017-2028) & (US$ Million)
Figure 85. Intramuscular Injectable Suspensions Value Chain
Figure 86. Intramuscular Injectable Suspensions Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

Global 2-Propylheptyl Acrylate (2-PHA) Market Insights, Forecast to 2028
QY2203B01339 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のアクリル酸2-プロピルヘプチル(2-PHA)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、20...

1,3-プロパンジオール (PDO)のグローバル市場インサイト・予測（～2028年）

Global 1,3-Propanediol(PDO) Market Insights and Forecast to 2028
QY2203B00031 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界の1,3-プロパンジオール (PDO)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

パンクレリパーゼのグローバル市場インサイト・予測（～2028年）

Global Pancrelipase Market Insights and Forecast to 2028
QY2203B05040 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のパンクレリパーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパンクレリパーゼの世...

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

Eインクスクリーンのグローバル市場インサイト・予測（～2028年）

Global E-ink Screens Market Insights and Forecast to 2028
QY2203B00584 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のEインクスクリーンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にEインクスクリーン...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

スピンオンドーパントのグローバル市場インサイト・予測（～2028年）

Global Spin-on Dopant Market Insights, Forecast to 2028
QY2203B03540 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピンオンドーパントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピンオンドーパ...

フルシトシン錠のグローバル市場インサイト・予測（～2028年）

Global Flucytosine Tablets Market Insights and Forecast to 2028
QY2203B05663 2022年3月 76Pages
新型コロナウイルス感染症のパンデミックにより、世界のフルシトシン錠の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフルシトシン錠の世界市...

スマートネックレスのグローバル市場インサイト・予測（～2028年）

Global Smart Necklace Market Insights and Forecast to 2028
QY2203B03621 2022年3月 74Pages
新型コロナウイルス感染症のパンデミックにより、世界のスマートネックレスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスマートネックレス...

遠心蒸発器のグローバル市場インサイト・予測（～2028年）

Global Centrifugal Evaporator Market Insights and Forecast to 2028
QY2203B07767 2022年3月 74Pages
新型コロナウイルス感染症のパンデミックにより、世界の遠心蒸発器の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に遠心蒸発器の世界市場のxx...

少量注射のグローバル市場 2021年：企業別、地域別、種類・用途別 The Small Volume Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
従来型PICC＆パワーインジェクタブルPICCのグローバル市場 2021年：企業別、地域別、種類・用途別 The Conventional PICC and Power-Injectable PICC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
注射型骨移植剤のグローバル市場 2021年：企業別、地域別、種類・用途別 The Injectable Bone Graft market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
粘膜黒色腫治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Mucosal Melanoma Treatment Market The global Mucosal Melanoma Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Surgical Resecti…
オンライン子供服・マタニティ服のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Online Children's and Maternity Apparel Market Due to the COVID-19 pandemic, the global Online Children's and Maternity Apparel market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % d…